30 to 40 countries unable to give second Covid-19 shots: WHO official

Between 30 to 40 countries are unable to provide second doses of a Covid-19 vaccine, especially those expecting jabs from AstraZeneca, officials of the World Health Organization (WHO) said.

coronavirus, vaccine, vaccination, covid-19
As of June 18, a total of 2,378,482,776 vaccine doses have been administered across the world, according to the WHO.
IANS Geneva
2 min read Last Updated : Jun 19 2021 | 1:03 PM IST

Between 30 to 40 countries are unable to provide second doses of a Covid-19 vaccine, especially those expecting jabs from AstraZeneca, officials of the World Health Organization (WHO) said.

"We have a huge number of countries currently that have had to suspend the rollout of their second doses of vaccine," Xinhua news agency quoted Bruce Aylward, Senior Advisor to the WHO Director-General on Organizational Change, as saying on Friday.

Many countries that were expecting AstraZeneca vaccines from the Serum Institute of India, distributed through WHO-led COVAX program, had seen their supplies being reduced as the manufacturer had to prioritize India's outbreak in April 2021.

Aylward said that countries in Sub-Saharan Africa, Latin America and the Middle East as well as neighbours of India, such as Nepal or Sri Lanka, are affected.

Many of these countries "are at the very end of the supply they have", said Katherine O'Brien, WHO Director of the Department of Immunization, Vaccines and Biologicals.

She added that countries with "weak" vaccination programs suffer from discontinued supplies, a situation that could create a loss of confidence among populations.

As of June 18, a total of 2,378,482,776 vaccine doses have been administered across the world, according to the WHO.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineWHOAstraZeneca

First Published: Jun 19 2021 | 12:30 PM IST

Next Story